Based in BLUE BELL, PA, OXFENDAZOLE DEVELOPMENT GROUP operates as a Public Charity. The organization reported $9K in revenue, $227K in expenses, $100K in total assets for fiscal year 2025. Imperigo tracks 4 reported grant relationships connected to this organization totaling approximately $1.9M.
The Oxfendazole Development Group is a 501c3 nonprofit organization formed and operated exclusively for charitable purposes specifically for the purpose of engaging in research and development of pharmaceutical treatments to help eliminate neglected tropical diseases NTDs and to facilitate access to such treatments for individuals in need.
Showing up to 5 of 4 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $9K | $227K | $100K |
| 2024 | $23K | $852K | $318K |
| 2023 | $59K | $605K | $1.1M |
| 2022 | $1.7M | $43K | $1.7M |
Between 2022 and 2025, reported annual revenue declined from $1.7M to $9K (-99%), with total assets most recently reported at $100K.
Interactive year-over-year charts and full filing details available with membership.
